1okz: Difference between revisions

From Proteopedia
Jump to navigationJump to search
OCA (talk | contribs)
No edit summary
OCA (talk | contribs)
No edit summary
Line 4: Line 4:


==Overview==
==Overview==
PDK1 (3-phosphoinositide-dependent protein kinase-1) is a member of the, AGC (cAMP-dependent, cGMP-dependent, protein kinase C) family of protein, kinases, and has a key role in insulin and growth-factor signalling, through phosphorylation and subsequent activation of a number of other AGC, kinase family members, such as protein kinase B. The staurosporine, derivative UCN-01 (7-hydroxystaurosporine) has been reported to be a, potent inhibitor for PDK1, and is currently undergoing clinical trials for, the treatment of cancer. Here, we report the crystal structures of, staurosporine and UCN-01 in complex with the kinase domain of PDK1. We, show that, although staurosporine and UCN-01 interact with the PDK1 active, site in an overall similar manner, the UCN-01 7-hydroxy group, which is, not present in staurosporine, generates direct and water-mediated hydrogen, bonds with active-site residues. Inhibition data from UCN-01 tested, against a panel of 29 different kinases show a different pattern of, inhibition compared with staurosporine. We discuss how these differences, in inhibition could be attributed to specific interactions with the, additional 7-hydroxy group, as well as the size of the, 7-hydroxy-group-binding pocket. This information could lead to, opportunities for structure-based optimization of PDK1 inhibitors.
PDK1 (3-phosphoinositide-dependent protein kinase-1) is a member of the AGC (cAMP-dependent, cGMP-dependent, protein kinase C) family of protein kinases, and has a key role in insulin and growth-factor signalling through phosphorylation and subsequent activation of a number of other AGC kinase family members, such as protein kinase B. The staurosporine derivative UCN-01 (7-hydroxystaurosporine) has been reported to be a potent inhibitor for PDK1, and is currently undergoing clinical trials for the treatment of cancer. Here, we report the crystal structures of staurosporine and UCN-01 in complex with the kinase domain of PDK1. We show that, although staurosporine and UCN-01 interact with the PDK1 active site in an overall similar manner, the UCN-01 7-hydroxy group, which is not present in staurosporine, generates direct and water-mediated hydrogen bonds with active-site residues. Inhibition data from UCN-01 tested against a panel of 29 different kinases show a different pattern of inhibition compared with staurosporine. We discuss how these differences in inhibition could be attributed to specific interactions with the additional 7-hydroxy group, as well as the size of the 7-hydroxy-group-binding pocket. This information could lead to opportunities for structure-based optimization of PDK1 inhibitors.


==About this Structure==
==About this Structure==
Line 13: Line 13:
[[Category: Homo sapiens]]
[[Category: Homo sapiens]]
[[Category: Single protein]]
[[Category: Single protein]]
[[Category: Transferred entry: 2.7.11.1]]
[[Category: Transferred entry: 2 7.11 1]]
[[Category: Aalten, D.M.F.Van.]]
[[Category: Aalten, D M.F Van.]]
[[Category: Alessi, D.R.]]
[[Category: Alessi, D R.]]
[[Category: Komander, D.]]
[[Category: Komander, D.]]
[[Category: Kular, G.S.]]
[[Category: Kular, G S.]]
[[Category: GOL]]
[[Category: GOL]]
[[Category: SO4]]
[[Category: SO4]]
Line 31: Line 31:
[[Category: ucn-01]]
[[Category: ucn-01]]


''Page seeded by [http://oca.weizmann.ac.il/oca OCA ] on Sun Feb 3 09:59:24 2008''
''Page seeded by [http://oca.weizmann.ac.il/oca OCA ] on Thu Feb 21 14:18:53 2008''